These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35156579)

  • 1. Cathepsin B-A Neuronal Death Mediator in Alzheimer's Disease Leading to Neurodegeneration.
    Sharma A; Swetha R; Bajad NG; Ganeshpurkar A; Singh R; Kumar A; Singh SK
    Mini Rev Med Chem; 2022; 22(15):2012-2023. PubMed ID: 35156579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    Hook G; Kindy M; Hook V
    J Alzheimers Dis; 2023; 93(1):33-46. PubMed ID: 36970896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
    Hook G; Hook V; Kindy M
    J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce beta-amyloid related to Alzheimer's disease.
    Hook V; Hook G; Kindy M
    Biol Chem; 2010 Aug; 391(8):861-72. PubMed ID: 20536395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.
    Hook V; Toneff T; Bogyo M; Greenbaum D; Medzihradszky KF; Neveu J; Lane W; Hook G; Reisine T
    Biol Chem; 2005 Sep; 386(9):931-40. PubMed ID: 16164418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease.
    Hook V; Schechter I; Demuth HU; Hook G
    Biol Chem; 2008 Aug; 389(8):993-1006. PubMed ID: 18979625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein.
    Hook VY; Kindy M; Hook G
    J Biol Chem; 2008 Mar; 283(12):7745-53. PubMed ID: 18184658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases.
    Armbrust F; Bickenbach K; Marengo L; Pietrzik C; Becker-Pauly C
    Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119164. PubMed ID: 34699873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics.
    Hook G; Hook VY; Kindy M
    Biol Chem; 2007 Sep; 388(9):979-83. PubMed ID: 17696783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein.
    Hook VY; Kindy M; Reinheckel T; Peters C; Hook G
    Biochem Biophys Res Commun; 2009 Aug; 386(2):284-8. PubMed ID: 19501042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models.
    Butler D; Hwang J; Estick C; Nishiyama A; Kumar SS; Baveghems C; Young-Oxendine HB; Wisniewski ML; Charalambides A; Bahr BA
    PLoS One; 2011; 6(6):e20501. PubMed ID: 21695208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin D: Analysis of its potential role as an amyloid beta degrading protease.
    Gallwitz L; Schmidt L; Marques ARA; Tholey A; Cassidy L; Ulku I; Multhaup G; Di Spiezio A; Saftig P
    Neurobiol Dis; 2022 Dec; 175():105919. PubMed ID: 36347423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
    Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
    J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
    Wang C; Sun B; Zhou Y; Grubb A; Gan L
    J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.